Clinicaltrial of poly herbal product in the treatment of hypertension

Category Primary study
JournalInternational Journal of Pharmaceutical Sciences and Research
Year 2014
Background: High blood pressure has emerged as a leading cause for death and disability worldwide.1 Management of hypertension effectively has been a distant reality. Hypercum, a rationale combination of herbs has shown to reduce BP effectively along with other benefits as studied in the ancient literatures and research publication. Objectives: The aim of the study is to evaluate the safety and efficacy of "Hypercum" on mild to moderate hypertension, an open labeled nonrandomized proof of concept study enrolled 16hypertensive associated with co-morbid conditions. Methods: patients, who met the selection criteria. The efficacy was assessed by measuring the blood pressure at baseline and on every 15 days till the BP got controlled and then every month and followed up for 84 days. The effect of Hypercum on other co-morbid conditions was also evaluated. The quality of life was also assessed using SF-30. Planned student't' test was applied. Results: At screening (before the enrollment for the study) the mean systolic blood pressure (SBP) was 161.25 mmHg and their mean diastolic blood pressure (DBP) was 106.88mmHg. The mean baseline systolic blood pressure, the mean diastolic blood pressure and the mean arterial blood pressure (MAP) were 152.50 mmHg, 99 mmHg and 113.88 mmHg respectively. The mean value of these parameters SBP, DBP and MAP decreased to 122.50 mmHg, 81.67 mmHg and 92.58 mmHg respectively at visit 5 that is at Day 84. There was significant reduction in systolic blood pressure, diastolic blood pressure and mean arterial blood pressure from baseline to the entire visit that is Day14, Day28, Day56 and Day84. Conclusion: "Hypercum" is effective in treating the mild to moderate hypertension associated with co-morbid conditions with positive outcome on the quality of life. © 2014 are reserved by International Journal of Pharmaceutical Sciences and Research.
Epistemonikos ID: 52d7e59f4c3613fa3179a6dbb8325fec741bc679
First added on: Feb 06, 2025